High Spy1 expression predicts poor prognosis in colorectal cancer

References

• SiegelRDesantisCJemalAColorectal cancer statistics, 2014CA Cancer J Clin201464210411724639052
   PubMed Web of Science ®Google Scholar
• DayLWVelayosFColorectal cancer screening and surveillance in the elderly: updates and controversiesGut Liver20159214315125721001
   PubMed Web of Science ®Google Scholar
• ZavoralMSuchanekSMajekOColorectal cancer screening: 20 years of development and recent progressWorld J Gastroenterol201420143825383424744575
   PubMed Web of Science ®Google Scholar
• BajenovaOChaikaNTolkunovaECarcinoembryonic antigen promotes colorectal cancer progression by targeting adherens junction complexesExp Cell Res2014324211512324726916
   PubMed Web of Science ®Google Scholar
• WangYRYanJXWangLNThe diagnostic value of serum carcinoembryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancerJ Cancer Res Ther201410Suppl30730925693941
   PubMedGoogle Scholar
• ShibutaniMMaedaKNagaharaHSignificance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage II colorectal cancerAnticancer Res20143473753375824982398
   PubMed Web of Science ®Google Scholar
• BrennerHStockCHoffmeisterMEffect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studiesBMJ2014348g246724922745
   PubMed Web of Science ®Google Scholar
• ByunJYYoonSJOhIHKimYASeoHYLeeYHEconomic burden of colorectal cancer in KoreaJ Prev Med Public Health2014472849324744825
   PubMedGoogle Scholar
• PickhardtPJHassanCHalliganSMarmoRColorectal cancer: CT colonography and colonoscopy for detection—systematic review and meta-analysisRadiology2011259239340521415247
   PubMed Web of Science ®Google Scholar
• LimSKaldisPCdks, cyclins and CKIs: roles beyond cell cycle regulationDevelopment2013140153079309323861057
   PubMed Web of Science ®Google Scholar
• McAndrewCWGastwirtRFDonoghueDJThe atypical CDK activator Spy1 regulates the intrinsic DNA damage response and is dependent upon p53 to inhibit apoptosisCell Cycle200981667519106603
   PubMed Web of Science ®Google Scholar
• McAndrewCWGastwirtRFMeyerANPorterLADonoghueDJSpy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27Cell Cycle20076151937194517671428
   PubMed Web of Science ®Google Scholar
• FerraiuoloRMTubmanJSinhaIHammCPorterLAThe cyclin-like protein, SPY1, regulates the ERα and ERK1/2 pathways promoting tamoxifen resistanceOncotarget2017814233372335228423577
   PubMedGoogle Scholar
• BarnesEAPorterLALenormandJLDellingerRWDonoghueDJHuman Spy1 promotes survival of mammalian cells following DNA damageCancer Res200363133701370712839962
   PubMed Web of Science ®Google Scholar
• Al SorkhyMFerraiuoloRMJaliliEThe cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancerBMC Cancer2012124522280365
   PubMed Web of Science ®Google Scholar
• ZucchiIMentoEKuznetsovVAGene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasisProc Natl Acad Sci U S A200410152181471815215608061
   PubMed Web of Science ®Google Scholar
• LuSLiuRSuMSpy1 participates in the proliferation and apoptosis of epithelial ovarian cancerJ Mol Histol2016471475726644004
   PubMed Web of Science ®Google Scholar
• KeQJiJChengCExpression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinomaExp Mol Pathol200987316717219686732
   PubMed Web of Science ®Google Scholar
• FeiMHangQHouSRuanCCell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cellsInt J Hematol201398444645524037419
   PubMed Web of Science ®Google Scholar
• PatelSHKneuertzPJDelgadoMClinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinomaAnn Surg Oncol201118123384339021590454
   PubMed Web of Science ®Google Scholar
• TangZLiCKangBGaoGLiCZhangZGEPIA: a web server for cancer and normal gene expression profiling and interactive analysesNucleic Acids Res201745W1W98W10228407145
   PubMed Web of Science ®Google Scholar
• BerlinJBendellJCHartLLA randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancerClin Cancer Res201319125826723082002
   PubMed Web of Science ®Google Scholar
• WangJXWuHLZhuMZhouRRole of anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy for metastatic colorectal cancer: an update meta-analysis of randomized clinical trialsPathol Oncol Res Epub2018130
   Web of Science ®Google Scholar
• KhattakMAMartinHDavidsonAPhillipsMRole of first-line antiepidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy in advanced colorectal cancer: a meta-analysis of randomized clinical trialsClin Colorectal Cancer2015142819025666296
   PubMed Web of Science ®Google Scholar
• SehdevACramerHMIbrahimAAYoungerAEO’NeilBHPathological complete response with anti-PD-1 therapy in a patient with microsatellite instable high, BRAF mutant metastatic colon cancer: a case report and review of literatureDiscov Med20162111734134727355330
   PubMed Web of Science ®Google Scholar
• TohJWTde SouzaPLimSHThe potential value of immunotherapy in colorectal cancers: review of the evidence for programmed death-1 inhibitor therapyClin Colorectal Cancer201615428529127553906
   PubMed Web of Science ®Google Scholar
• ZhangJZhouLZhaoSDickerDTEl-DeiryWSThe CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxiaCell Cycle201716121193120028486050
   PubMed Web of Science ®Google Scholar
• PinoMSChungDCThe chromosomal instability pathway in colon cancerGastroenterology201013862059207220420946
   PubMed Web of Science ®Google Scholar
• IssaJPColon cancer: it’s CIN or CIMPClin Cancer Res200814195939594018829469
   PubMed Web of Science ®Google Scholar
• VermeulenKVan BockstaeleDRBernemanZNThe cell cycle: a review of regulation, deregulation and therapeutic targets in cancerCell Prolif200336313114912814430
   PubMed Web of Science ®Google Scholar
• KaraiskouAPerezLHFerbyIOzonRJessusCNebredaARDifferential regulation of Cdc2 and Cdk2 by RINGO and cyclinsJ Biol Chem200127638360283603411461916
   PubMed Web of Science ®Google Scholar
• PorterLAKong-BeltranMDonoghueDJSpy1 interacts with p27Kip1 to allow G1/S progressionMol Biol Cell20031493664367412972555
   PubMed Web of Science ®Google Scholar
• PorterLADellingerRWTynanJAHuman Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2J Cell Biol2002157335736611980914
   PubMed Web of Science ®Google Scholar
• ArumugamKMacNicolMCWangYRingo/cyclin-dependent kinase and mitogen-activated protein kinase signaling pathways regulate the activity of the cell fate determinant Musashi to promote cell cycle re-entry in Xenopus oocytesJ Biol Chem201228713106391064922215682
   PubMed Web of Science ®Google Scholar
• NebredaARCDK activation by non-cyclin proteinsCurrent Opinion in Cell Biology200618219219816488127
   PubMed Web of Science ®Google Scholar